62 results
Page 2 of 4
8-K
EX-99.1
5aae8d ybiuro
2 Nov 23
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
gr1yr9axx3
11 Oct 23
Regulation FD Disclosure
9:26am
8-K
EX-3.1
v6z pk3e4z1
22 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
EX-99.1
fgqmm
23 Aug 23
Enrolled 52 participants with Developmental and Epileptic Encephalopathies (DEEs) into the PACIFIC Study
8:46am
8-K
tnuqz5qcuu
23 Aug 23
Enrolled 52 participants with Developmental and Epileptic Encephalopathies (DEEs) into the PACIFIC Study
8:46am
424B5
65kh3zwo873atkq8g
4 Aug 23
Prospectus supplement for primary offering
4:20pm
8-K
EX-99.1
ddoc1cj182zsowp0
3 Aug 23
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:12pm
8-K
EX-99.1
7rs02zpy
9 May 23
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
31ihl0168g
5 Dec 22
Regulation FD Disclosure
8:45am
8-K
s7ew29ttci
5 Dec 22
Regulation FD Disclosure
8:45am
S-3
j2i cjt18
30 Sep 22
Shelf registration
4:11pm
S-3
EX-1.2
tvmam
30 Sep 22
Shelf registration
4:11pm
DEF 14A
dl6co 1rom
13 Apr 22
Definitive proxy
4:15pm